Drug intelligence / Profile preview

Triacylglycerols containing medium- and long-chain fatty acids

Development stage: Preclinical
Administration: Oral

Overview

Triacylglycerols containing medium- and long-chain fatty acids (TML) are a type of lipid composed of both medium- and long-chain fatty acids within the same molecule. Studies suggest that dietary TML may have the potential to prevent hypertriglyceridemia and obesity, as evidenced by a significant reduction in the rate of variation of serum triacylglycerol concentration and body fat mass compared to soybean oil in a clinical study. The exact molecular mechanism of action is not detailed, but its effects are attributed to its unique fatty acid composition influencing lipid metabolism.

Beyond the preview

Go deeper on Triacylglycerols containing medium- and long-chain fatty acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triacylglycerols containing medium- and long-chain fatty acids.

Explore the full profile